(NewsNation) — The U.S. Food and Drug Administration is conducting a review of the abortion drug mifepristone, to determine if there are any risks or safety concerns with its use.

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr sent a letter on September 19 to Republican attorneys general, explaining that the FDA had "received reports of serious adverse events in patients who took mifepristone." In the letter obtained by NewsNation, Kennedy said the FDA would be conducting its own review of evidence to determine whether any modifications to the drug's use would be necessary.

Reproductive Freedom for All, a nonprofit, is pushing back against the FDA review, arguing that mifepristone is safe and that the study could place "dangerous restrictions" on abortion access.

"Mife

See Full Page